Inhaled Steroids and Airway Remodelling in Asthma

Acta Biomedica de l'Ateneo Parmense

Volumn 74, Issue 3, 2003, Pages 121-125

  Chetta, Alfredo ^a,b   Marangio, Emilio ^a   Olivieri, Dario ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Airway remodelling; Asthma; Steroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE; METHACHOLINE; STEROID;

AIRWAY DYNAMICS; AIRWAY OBSTRUCTION; ASTHMA; BASEMENT MEMBRANE; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CHRONIC INFLAMMATION; HUMAN; INDIVIDUALITY; INFLAMMATORY CELL; RESPIRATORY FUNCTION; REVIEW; STEROID THERAPY; STRUCTURE ANALYSIS; THICKNESS; VASCULAR DISEASE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AIRWAY OBSTRUCTION; ASTHMA; BRONCHI; EDEMA; HUMANS; HYPERPLASIA; HYPERTROPHY;

EID: 1542725079     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. WHO/NhLBI Workshop Report: 1995. Global strategy for asthma management and prevention. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD. Publication No. 95-3659.
2. Bousquet J, Jeffery PK, Busse WW, et al. State of art. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720-45.
3. Kips IC, Pauwels RA. Airway wall remodelling: does it occur and what does it mean. Clin Exp Allergy 1999; 29: 1457-66.
4. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147: 405-10.
5. Takizawa T, Thurlbeck WM. Muscle and musous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis. Am Rev Respir Dis 1971; 104: 331-6.
6. Chetta A, Foresi A, Del Donno M, et al. airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997; 111: 852-7.
7. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
8. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156: 229-33.
9. Woolcock AJ, Salome CM, Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130: 71-5.
10. King GG, Paré PD, Seow CY. The mechanics of exaggerated airway narrowing in asthma: th erole of smooth muscle. Respir Physiol 1999; 118: 1-13.
11. Sullivan P, Stephens D, Ansari T, et al. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J 1998; 12: 811-5.
12. Lötvall J, Inman N, O'Byrne P. Measurement of airway hyperresponsiveness: new considerations. Thorax 1998; 53: 419-24.
13. Chetta A, Foresi A, Del Donno M, et al. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 1996; 153: 910-7.
14. Hoshino M, Nakamura Y, Sim JJ, et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-1expression in bronchial asthma. Clin Exp Allergy 1998; 28: 568-77.
15. Laprise C, Laviolette M, Boutet M, et al. Asymptomatic airway hyperresponsiveness: relationship with airway inflammation and remodelling. Eur Respir J 1999; 14: 63-73.
16. Brewster CE, Howarth PH, Djukanovic R, et al. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3: 507-11.
17. Boulet LP, Belanger M, Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med 1995; 152: 865-71.
18. Hudon C, Turcotte H, Laviolette M, et al. Characteristics of bronchial asthma with incomplete revesibility of airflow obstruction. Ann Allergy Asthma Immunol 1997; 78: 195-202.
19. Cade J and Pain M. Pulmonary function during clinical remission of asthma: how reversible is asthma? Aust NZJ Med 1973; 3: 545-51.
20. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70: 171-9.
21. Wang JH, Trigg CJ, Devalia JL, et al. Efect of inhaled beclomethasone dipropionate on expresion of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma. J Allergy Clin Immunol 1994; 94: 1025-34.
22. Booth H, Richmond I, Ward C, et al. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 1995; 152: 45-52.
23. Nauck M, Karakiulakis G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998; 341: 309-15.
24. Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 2001; 31: 722-30.
25. Orsida BE, Li X, Hickey B, et al. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999; 54: 289-95.
26. 2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001; 164: 117-21.
27. Olivieri D, Chetta A, Del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155: 1864-71.
28. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57: 309-16.
29. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150: 17-22.
30. Jeffery PK, Godfrey RW, Adelroth E, et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992; 145: 890-9.
31. Chetta A, Zanini A, Foresi A, et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med 2003; 167: 751-7.